Literature DB >> 11990385

Metastatic medulloblastoma--therapeutic success through molecular target identification?

M C Frühwald, C Plass.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11990385     DOI： 10.1038/sj.tpj.6500077

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  4 in total

1.  Heparanase expression and TrkC/p75NTR ratios in human medulloblastoma.

Authors:  Neeta D Sinnappah-Kang; Robert E Mrak; Daniel B Paulsen; Dario Marchetti
Journal:  Clin Exp Metastasis       Date:  2006-07-07       Impact factor: 5.150

2.  Secreted meningeal chemokines, but not VEGFA, modulate the migratory properties of medulloblastoma cells.

Authors:  Monika A Davare; Sangeet Lal; Jennifer L Peckham; Suresh I Prajapati; Sakir H Gultekin; Brian P Rubin; Charles Keller
Journal:  Biochem Biophys Res Commun       Date:  2014-06-10       Impact factor: 3.575

3.  Frequent but borderline methylation of p16 (INK4a) and TIMP3 in medulloblastoma and sPNET revealed by quantitative analyses.

Authors:  J Mühlisch; T Bajanowski; C H Rickert; W Roggendorf; G Würthwein; H Jürgens; M C Frühwald
Journal:  J Neurooncol       Date:  2007-01-06       Impact factor: 4.506

4.  IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.

Authors:  Matthew N Svalina; Ken Kikuchi; Jinu Abraham; Sangeet Lal; Monika A Davare; Teagan P Settelmeyer; Michael C Young; Jennifer L Peckham; Yoon-Jae Cho; Joel E Michalek; Brian S Hernandez; Noah E Berlow; Melanie Jackson; Daniel J Guillaume; Nathan R Selden; Darell D Bigner; Kellie J Nazemi; Sarah C Green; Christopher L Corless; Sakir Gultekin; Atiya Mansoor; Brian P Rubin; Randall Woltjer; Charles Keller
Journal:  Sci Rep       Date:  2016-06-03       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.